PRESS RELEASE published on 05/17/2023 at 12:30, 3 years 2 months ago Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis
PRESS RELEASE published on 05/06/2023 at 12:30, 3 years 3 months ago Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action
PRESS RELEASE published on 05/04/2023 at 12:30, 3 years 3 months ago Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders
PRESS RELEASE published on 04/27/2023 at 12:30, 3 years 3 months ago Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.
PRESS RELEASE published on 04/26/2023 at 12:30, 3 years 3 months ago Immunic to Participate in Investor and Scientific Conferences in May
PRESS RELEASE published on 04/05/2023 at 12:30, 3 years 4 months ago Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe Ulcerative Colitis
PRESS RELEASE published on 03/02/2023 at 12:30, 3 years 5 months ago Immunic to Participate in Investor and Scientific Conferences in March
PRESS RELEASE published on 02/22/2023 at 12:30, 3 years 5 months ago Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at ACTRIMS Forum 2023
PRESS RELEASE published on 02/09/2023 at 12:30, 3 years 6 months ago Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need
PRESS RELEASE published on 01/25/2023 at 12:30, 3 years 6 months ago Immunic to Participate in Scientific and Investor Conferences in February
Published on 08/12/2026 at 09:01, 1 hour 15 minutes ago Apex Drills 4.48% REO Over 8.0 m and 5.27% REO Over 10.2 m Within Multiple ~ 150 m Intervals of > 2.00 % REO at the Rift Rare Earth Project in SE Nebraska
Published on 08/12/2026 at 08:02, 2 hours 14 minutes ago Southern Energy Corp. Announces Spudding of Cotton Valley Test Well at Williamsburg and Appointment of Market Maker
Published on 08/12/2026 at 08:00, 2 hours 16 minutes ago Galantas Selects Engineering and Mine Planning Contractors for Andacollo Gold Project
Published on 08/12/2026 at 00:00, 10 hours 16 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 10 hours 36 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/12/2026 at 10:06, 10 minutes ago Exasol AG: First half of 2026 marked by cautious investment by existing customers – strategic focus on data sovereignty and AI drives momentum in new customer business
Published on 08/12/2026 at 10:05, 11 minutes ago EQS-Adhoc: Exasol AG revises guidance for fiscal year 2026
Published on 08/12/2026 at 10:00, 16 minutes ago FUCHS announces grand opening of Americas Technology Center in Massachusetts
Published on 08/12/2026 at 10:00, 16 minutes ago CEOTRONICS AG receives order worth approximately €1.9 Million
Published on 08/12/2026 at 10:00, 16 minutes ago AI agents for insurers: IT service provider adesso acquires leading AI claims platform omni:us
Published on 08/10/2026 at 18:00, 1 day 16 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 22 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 22 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days ago Number of shares and voting rights - July 2026 (In French only)
